"Alphapapillomavirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of DNA viruses in the family PAPILLOMAVIRIDAE. They preferentially infect the anogenital and ORAL MUCOSA in humans and primates, causing both malignant and benign neoplasms. Cutaneous lesions are also seen.
Descriptor ID |
D052685
|
MeSH Number(s) |
B04.280.210.655.050 B04.613.204.655.050
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Alphapapillomavirus".
Below are MeSH descriptors whose meaning is more specific than "Alphapapillomavirus".
This graph shows the total number of publications written about "Alphapapillomavirus" by people in this website by year, and whether "Alphapapillomavirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 0 | 2 | 2 |
2016 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 2 | 1 | 3 |
2021 | 6 | 2 | 8 |
2022 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Alphapapillomavirus" by people in Profiles.
-
Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018. Cancer Prev Res (Phila). 2022 11 01; 15(11):777-784.
-
Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers. Clin Cancer Res. 2022 10 14; 28(20):4479-4493.
-
Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention. BMC Pediatr. 2022 09 12; 22(1):541.
-
Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2022 11 01; 128(21):3831-3842.
-
Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas. Am J Public Health. 2022 09; 112(9):1269-1272.
-
Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic. Expert Rev Anticancer Ther. 2022 07; 22(7):751-761.
-
Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022 08 01; 113(5):1054-1062.
-
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer. J Natl Cancer Inst. 2022 04 11; 114(4):609-617.
-
Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status. Clin Infect Dis. 2022 04 09; 74(7):1230-1236.
-
Eosinophilic homogeneous intracytoplasmic inclusion bodies: Unique viral cytopathic changes associated with epidermodysplasia verruciformis and human papillomavirus type 49. J Cutan Pathol. 2022 Jul; 49(7):658-662.